Novavax director granted RSUs and stock options
Novavax director John W. Shiver received new equity awards as part of his board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Novavax director John W. Shiver received new equity awards as part of his board compensation. On June 18, 2026, he was granted 14,180 restricted stock units, each representing one share of Novavax common stock. He was also granted stock options on 21,270 shares at an exercise price of $9.13 per share.
Both the RSUs and the options were awarded under Novavax’s Amended and Restated 2015 Stock Incentive Plan. According to the terms, all of the shares subject to each grant vest on the first anniversary of the June 18, 2026 grant date, if he continues serving on the board through that date.
Insider Trade Summary
Grant/Award: 35,450 shares
Grant/Award
2 txns
Insider
Shiver John W.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 21,270 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 14,180 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,270 contracts (Direct);
Restricted Stock Units — 14,180 contracts (Direct)
Footnotes (3)
- F1. One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- F3. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
Key Figures
RSU grant size: 14,180 units
Option grant size: 21,270 options
Option exercise price: $9.13 per share
+3 more
6 metrics
RSU grant size
14,180 units
Restricted Stock Units granted June 18, 2026
Option grant size
21,270 options
Stock Option (Right to Buy) granted June 18, 2026
Option exercise price
$9.13 per share
Conversion or exercise price for stock options
Option expiration
June 18, 2036
Expiration date of stock options
RSUs following transaction
14,180 units
Total RSUs held after grant
Options following transaction
21,270 options
Total options held after grant
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), Amended and Restated 2015 Stock Incentive Plan, restricted stock unit ("RSU")
4 terms
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Amended and Restated 2015 Stock Incentive Plan financial
"shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended"
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the latest Novavax (NVAX) Form 4 filing report for John W. Shiver?
The Form 4 shows Novavax director John W. Shiver received equity compensation grants. He was awarded 14,180 restricted stock units and stock options on 21,270 shares, reflecting routine board compensation rather than open-market stock purchases or sales.
How many RSUs did Novavax (NVAX) grant to director John W. Shiver?
Novavax granted John W. Shiver 14,180 restricted stock units. Each RSU represents a right to receive one share of Novavax common stock, subject to vesting based on his continued service on the company’s board of directors through the specified vesting date.
What stock options were granted to John W. Shiver in the Novavax (NVAX) Form 4?
Shiver received stock options covering 21,270 shares of Novavax common stock with an exercise price of $9.13 per share. These options were granted under the company’s 2015 Stock Incentive Plan and have an expiration date of June 18, 2036, subject to vesting conditions.
Are the Novavax (NVAX) Form 4 transactions open-market buys or sells?
The reported transactions are not open-market buys or sells. They are compensation-related equity awards: grants of restricted stock units and stock options to a director, classified as acquisitions under transaction code “A” rather than purchases or sales in the open market.
How do the Novavax (NVAX) RSU and option grants to John W. Shiver vest?
Both the RSU and option grants are scheduled to vest 100% on the first anniversary of the June 18, 2026 grant date. Vesting is conditioned on Shiver’s continued service on Novavax’s board of directors through that one-year vesting date under the plan terms.
Under which plan were John W. Shiver’s Novavax (NVAX) equity awards granted?
The RSUs and stock options were granted under Novavax’s Amended and Restated 2015 Stock Incentive Plan, as amended. This plan governs the terms of the awards, including vesting schedules, exercise price for options, and service requirements for directors receiving equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates